Corpay, Inc $CPAY Stock Sold by Provident Investment Management Inc.

Provident Investment Management Inc. decreased its holdings in Corpay, Inc (NYSE:CPAY) by 33.1% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 113,237 shares of the corporate payments company’s stock after selling 56,031 shares during the quarter. Corpay comprises about 4.4% of Provident Investment Management Inc.’s investment portfolio, making the stock its 8th largest holding. Provident Investment Management Inc.’s holdings in Corpay were worth $44,004,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of CPAY. Valley National Advisers Inc. raised its stake in shares of Corpay by 40,105.9% in the third quarter. Valley National Advisers Inc. now owns 6,835 shares of the corporate payments company’s stock valued at $2,428,000 after acquiring an additional 6,818 shares in the last quarter. Radnor Capital Management LLC grew its stake in Corpay by 14.9% during the 3rd quarter. Radnor Capital Management LLC now owns 11,355 shares of the corporate payments company’s stock worth $4,362,000 after purchasing an additional 1,470 shares in the last quarter. Signaturefd LLC grew its stake in Corpay by 172.9% during the 3rd quarter. Signaturefd LLC now owns 1,542 shares of the corporate payments company’s stock worth $569,000 after purchasing an additional 977 shares in the last quarter. Citizens Financial Group Inc. RI grew its stake in Corpay by 1,373.1% during the 3rd quarter. Citizens Financial Group Inc. RI now owns 15,350 shares of the corporate payments company’s stock worth $5,521,000 after purchasing an additional 14,308 shares in the last quarter. Finally, Sowell Financial Services LLC acquired a new position in Corpay during the 3rd quarter worth $373,000. Hedge funds and other institutional investors own 98.84% of the company’s stock.

Insider Buying and Selling at Corpay

In related news, Director Steven Stull sold 4,000 shares of the stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $410.66, for a total value of $1,642,640.00. Following the transaction, the director owned 23,598 shares of the company’s stock, valued at $9,690,754.68. This represents a 14.49% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Ronald Clarke sold 119,486 shares of the firm’s stock in a transaction on Tuesday, August 25th. The shares were sold at an average price of $412.40, for a total value of $49,276,026.40. Following the completion of the sale, the chief executive officer owned 2,354,330 shares in the company, valued at approximately $970,925,692. This represents a 4.83% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 220,860 shares of company stock worth $91,395,514 in the last three months. 5.19% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

CPAY has been the topic of a number of analyst reports. Wolfe Research increased their price target on Corpay from $475.00 to $530.00 and gave the company an “outperform” rating in a research report on Tuesday, August 25th. JPMorgan Chase & Co. lifted their price objective on Corpay from $400.00 to $470.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. Wall Street Zen downgraded Corpay from a “buy” rating to a “hold” rating in a research report on Saturday. Weiss Ratings raised Corpay from a “buy (b-)” rating to a “buy (b)” rating in a research report on Thursday, October 8th. Finally, Keefe, Bruyette & Woods upped their target price on shares of Corpay from $400.00 to $470.00 and gave the stock an “outperform” rating in a research note on Thursday, August 6th. Twelve analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $438.93.

Corpay Price Performance

Shares of CPAY opened at $408.95 on Monday. Corpay, Inc has a twelve month low of $252.84 and a twelve month high of $427.46. The firm’s fifty day simple moving average is $404.60 and its 200-day simple moving average is $372.84. The firm has a market capitalization of $26.85 billion, a price-to-earnings ratio of 24.89, a PEG ratio of 1.12 and a beta of 0.89. The company has a current ratio of 0.97, a quick ratio of 0.97 and a debt-to-equity ratio of 1.70.

Corpay (NYSE:CPAY) last released its quarterly earnings data on Wednesday, August 5th. The corporate payments company reported $7.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.58 by $0.42. The business had revenue of $1.34 billion during the quarter, compared to analysts’ expectations of $1.30 billion. Corpay had a net margin of 22.72% and a return on equity of 42.18%. The company’s revenue for the quarter was up 21.5% on a year-over-year basis. During the same period in the previous year, the company earned $5.13 EPS. Corpay has set its Q3 2026 guidance at 7.050-7.250 EPS and its FY 2026 guidance at 27.150-27.550 EPS. Equities analysts forecast that Corpay, Inc will post 25.79 EPS for the current fiscal year.

About Corpay

Corpay is a global corporate payments company that provides businesses with a range of payment and expense management solutions. Its services are designed to help organizations manage payables, card programs, travel and fleet-related expenses, and cross-border transactions more efficiently.

The company serves customers across a variety of industries and geographies, offering software and payment tools that streamline accounts payable, vendor payments, and workforce payments. Corpay also provides specialized solutions for fleet management and international payments, helping businesses control costs and simplify financial operations.

Corpay operates as part of the broader financial technology and payment processing sector.